Your browser doesn't support javascript.
loading
A revised biosynthetic pathway for the cofactor F420 in prokaryotes.
Bashiri, Ghader; Antoney, James; Jirgis, Ehab N M; Shah, Mihir V; Ney, Blair; Copp, Janine; Stuteley, Stephanie M; Sreebhavan, Sreevalsan; Palmer, Brian; Middleditch, Martin; Tokuriki, Nobuhiko; Greening, Chris; Scott, Colin; Baker, Edward N; Jackson, Colin J.
Afiliação
  • Bashiri G; School of Biological Sciences and Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Auckland, 1010, New Zealand. g.bashiri@auckland.ac.nz.
  • Antoney J; Synthetic Biology Future Science Platform, CSIRO Land and Water, Canberra, 2601, ACT, Australia.
  • Jirgis ENM; Research School of Chemistry, Australian National University, Acton, 2601, ACT, Australia.
  • Shah MV; School of Biological Sciences and Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Auckland, 1010, New Zealand.
  • Ney B; Synthetic Biology Future Science Platform, CSIRO Land and Water, Canberra, 2601, ACT, Australia.
  • Copp J; Synthetic Biology Future Science Platform, CSIRO Land and Water, Canberra, 2601, ACT, Australia.
  • Stuteley SM; Research School of Chemistry, Australian National University, Acton, 2601, ACT, Australia.
  • Sreebhavan S; Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada.
  • Palmer B; School of Biological Sciences and Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Auckland, 1010, New Zealand.
  • Middleditch M; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, 1010, New Zealand.
  • Tokuriki N; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, 1010, New Zealand.
  • Greening C; School of Biological Sciences and Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Auckland, 1010, New Zealand.
  • Scott C; Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada.
  • Baker EN; Synthetic Biology Future Science Platform, CSIRO Land and Water, Canberra, 2601, ACT, Australia.
  • Jackson CJ; School of Biological Sciences, Monash University, Clayton, 3800, VIC, Australia.
Nat Commun ; 10(1): 1558, 2019 04 05.
Article em En | MEDLINE | ID: mdl-30952857
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Riboflavina / Escherichia coli / Vias Biossintéticas Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Riboflavina / Escherichia coli / Vias Biossintéticas Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article